Company Projected Revenue: Encompass Health Inc. (EHC)

Encompass Health Inc. - graphic logo of issuer EHC

Risks for Encompass Health (EHC) are linked to government reimbursement rates and labor shortages, which are weighing on margins. However, its status as a rehabilitation leader and partnerships with clinics create a powerful defensive moat. This chart of the company's projected sales visualizes this resilience, where the value 6.63 denotes the current metric. Increasing center occupancy driven by an aging population serves as the primary catalyst for long-term business growth.

Company Expected Revenue: Encompass (EHC) for 07/04/2022 - 11/13/2026

Analytical breakdowns and data insights for company Encompass Health Corp (EHC)

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Basic company analysis:Encompass Health EHC
Signature product of Encompass Health Inc.

Encompass Health (EHC) is strengthening its market position through integration with hospital networks, which directly impacts projected revenue. By analyzing the organization's prospective sales valuation, an investor can discern the issuer's comparative commercial revenue potential relative to the sector, allowing for the identification of hidden costs and the protection of capital from depreciation during price stagnation, thereby confirming the long-term sustainability of the business model.

Direct competitors

Company Projected Revenue HCA Healthcare, Inc. (HCA)|THC - Company Expected Sales Volume|Company Projected Revenue Fresenius Medical Care AG & Co. KGaA FMS|SOLV - Company Future Sales Volume|UHS - Company Projected Revenue|Company Expected Revenue DVA|RDNT: Projected Sales Volume|optioncarehealth.com (OPCH) - Projected Sales Volume|Company Projected Revenue Surgery Partners|Premier Inc (PINC) - Company Future Sales|Company Projected Revenue National Vision Corp (EYE)|Company Future Sales Progyny Corp|Ardent Health Partners, Inc. - Company Future Sales Volume|Company Future Revenue SEM|Astrana Health - Projected Sales Volume|Company Future Revenue MD (Pediatrix)|USPH: Projected Sales Volume|Company Expected Sales Volume The Pennant Group Corp (PNTG)|ORGO (Organogenesis Holdings) - Projected Sales Volume|Projected Sales Volume nutexhealth.com|Company Projected Revenue Auna (AUNA)|Company Projected Revenue SBC (SBC Medical Group)|Jeuveau - Company Future Sales Volume|Company Projected Revenue Volume CYH (Community Health Corp)|Beauty Health - Projected Sales Volume|Company Future Revenue MDWD (MediWound Ltd.)|BTMD: Projected Sales Volume|Company Expected Sales Volume The Joint Corp (JYNT)|DCGO (DocGo Inc) - Projected Sales Volume|PIII: Company Future Revenue|Projected Sales Volume GANX|Company Future Sales Volume euda.com EUDA|Basel Medical Group Ltd - Company Future Sales Volume|Company Projected Revenue Volume CLGN (CollPlant)|CUPR - Company Projected Revenue|Company Future Revenue CCM (Concord Medical Corp)|AMS: Projected Sales Volume|Company Expected Sales Volume medirom.co.jp (MRM)|ALBT (Avalon GloboCare Corp) - Projected Sales Volume|Projected Sales Volume DIH Holding US|Company Future Sales Volume XAGE (Longevity Health Holdings Inc)|Company Projected Revenue Volume NIVF|Company Projected Revenue ATI Physical Therapy, Inc. ATIP|CMAX - Company Future Sales Volume|Kindly MD - Projected Sales Volume|Company Expected Sales Volume ModivCare Inc|Novo Integrated (NVOS) - Company Projected Revenue|Company Revenue Forecast SSY|Company Future Sales Volume BACK